FdaApplication
ANDA 210022
Identifiers
- fda_app_no: ANDA210022
Properties
| Property | Value |
|---|---|
| applicant_name | CADILA PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2023-02-24 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OLANZAPINE | OLANZAPINE | 20MG | TABLET;ORAL |
| OLANZAPINE | OLANZAPINE | 5MG | TABLET;ORAL |
| OLANZAPINE | OLANZAPINE | 15MG | TABLET;ORAL |
| OLANZAPINE | OLANZAPINE | 7.5MG | TABLET;ORAL |
| OLANZAPINE | OLANZAPINE | 10MG | TABLET;ORAL |
| OLANZAPINE | OLANZAPINE | 2.5MG | TABLET;ORAL |
6 products